Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
This is a randomized controlled trial over 5 years, using Stage II of the NIH-defined stage model for behavioral intervention development. We will evaluate the efficacy of the sleep intervention program (Care2Sleep) on sleep, health status measures, and quality of life (for dyads), and inflammation (for caregivers only). Eligible participants will be randomly assigned to in-person Care2Sleep, telehealth Care2Sleep, or to an in-person education control group. The Care2Sleep programs and the control education program will consist of five sessions. The intervention and control programs will begin after baseline assessment and randomization. Posttreatment assessments will be performed immediately after the last session and at 6-month follow-up.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria for Patients
Inclusion Criteria for Caregivers
Exclusion Criteria:
Primary purpose
Allocation
Interventional model
Masking
672 participants in 3 patient groups, including a placebo group
Loading...
Central trial contact
Yeonsu Song
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal